Abstract
Twenty six compounds (coumarins, flavonoids and alkaloids) were evaluated for their ability to inhibit the growth of three human tumor cell lines: breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and melanoma (A375-C5). Three of them [3-hydroxyflavone (6), 2’-hydroxy-3,4,4’,5,6’-pentamethoxychalcone (11), Siderin (20)] were very potent in inhibiting all human tumor cell lines tested. The structure / activity relationship is discussed.
Keywords: Alkaloids, coumarins, flavonoids, tumor cell lines growth inhibitor.
Anti-Cancer Agents in Medicinal Chemistry
Title:Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines
Volume: 13 Issue: 10
Author(s): Cristiane M. Cazal, Kantima Choosang, Vanessa Gisele P. Severino, João B. Fernandes, Maria Fátima G. F. da Silva, Paulo C. Vieira, Maria S. J. Nascimento, Gabriela M. Almeida, M. Helena Vasconcelos, Pannee Pakkong and Madalena M. M. Pinto
Affiliation:
Keywords: Alkaloids, coumarins, flavonoids, tumor cell lines growth inhibitor.
Abstract: Twenty six compounds (coumarins, flavonoids and alkaloids) were evaluated for their ability to inhibit the growth of three human tumor cell lines: breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and melanoma (A375-C5). Three of them [3-hydroxyflavone (6), 2’-hydroxy-3,4,4’,5,6’-pentamethoxychalcone (11), Siderin (20)] were very potent in inhibiting all human tumor cell lines tested. The structure / activity relationship is discussed.
Export Options
About this article
Cite this article as:
Cazal M. Cristiane, Choosang Kantima, Severino Gisele P. Vanessa, Fernandes B. João, Silva Fátima G. F. da Maria, Vieira C. Paulo, Nascimento S. J. Maria, Almeida M. Gabriela, Vasconcelos Helena M., Pakkong Pannee and Pinto M. M. Madalena, Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines, Anti-Cancer Agents in Medicinal Chemistry 2013; 13 (10) . https://dx.doi.org/10.2174/1871520613666131125122857
DOI https://dx.doi.org/10.2174/1871520613666131125122857 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Survey on the Usage of Supplements in Canadian Patients Living with HIV
Current HIV Research Use of Osmotic Dehydration to Improve Fruits and Vegetables Quality During Processing
Recent Patents on Food, Nutrition & Agriculture Impact of Red Wine Consumption on Cardiovascular Health
Current Medicinal Chemistry Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Status of Cytokines in Ischemia Reperfusion Induced Heart Injury
Cardiovascular & Hematological Disorders-Drug Targets Aging as an Evolvability-Increasing Program Which can be Switched Off by Organism to Mobilize Additional Resources for Survival
Current Aging Science Structural and Functional Characterization of a Mutant of Pseudocerastes persicus Natriuretic Peptide
Protein & Peptide Letters Editorial: Effect of Statins on Rates of Long-Term Cardiovascular Events and Restenosis Following Carotid Endarterectomy
Current Vascular Pharmacology Arterial Thickness and Immunometabolism: The Mediating role of Chronic Exercise
Current Cardiology Reviews Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Vascular C-Reactive Protein in the Pathogenesis of Coronary Artery Disease:Role of Vascular Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders-Drug Targets Lipid Management for the Prevention of Cardiovascular Disease
Current Pharmaceutical Design Current Treatment of Psoriasis with Biologics
Current Drug Discovery Technologies Ezetimibe and Vascular Endothelial Function
Current Vascular Pharmacology MicroRNAs in the Management of Heart Failure
Current Medicinal Chemistry Cardiac Resynchronization Therapy in Children
Current Cardiology Reviews Future Challenges for Microsomal Transport Protein Inhibitors
Current Vascular Pharmacology Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design